JAK2 and leukemia: Furthermore, either inhibitors alone was less capable to induce apoptosis in 32Dp210 T315I cells, compared to combinational treatment with both TG101209 and AUY922 (Figure 3B), suggesting the synergistic effect of using both JAK2 and HSP90 inhibitors at a relatively low concentration to kill IM-resistant leukemia cells.